CRISPR Therapeutics AG
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 1,680 | 0.0% | 32,039 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,084 | 0.0% | 32,156 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 1,174 | 0.0% | 24,129 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 786 | 0.0% | 23,093 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 874 | 0.0% | 22,217 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,013 | 0.0% | 21,572 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 1,160 | 0.0% | 21,474 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 1,335 | 0.0% | 19,590 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 1,287 | 0.0% | 20,559 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 841 | 0.0% | 18,527 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 935 | 0.0% | 16,648 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 715 | 0.0% | 15,806 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 605 | 0.0% | 14,875 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 900 | 0.0% | 13,778 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 2,929 | 0.0% | 48,205 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 3,253 | 0.0% | 51,817 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 4,084 | 0.0% | 53,891 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 5,178 | 0.0% | 46,264 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 7,355 | 0.0% | 45,433 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 4,797 | 0.0% | 39,367 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 5,429 | 0.0% | 35,460 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 2,051 | 0.0% | 24,519 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 1,723 | 0.0% | 23,445 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 807 | 0.0% | 19,039 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 1,181 | 0.0% | 19,399 | 12/31/2019 |